Clozapine And NotChristopher G. Goetz
List of bibliographic references
Number of relevant bibliographic references: 28.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000B50 | Alessandro Rotondo [Italie] ; Domenico Bosco [Italie] ; Massimiliano Plastino [Italie] ; Arturo Consoli [Italie] ; Francesca Bosco [Italie] | Clozapine for Medication-Related Pathological Gambling in Parkinson Disease |
| 001D33 | Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Michael S. Okun [États-Unis] | Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease |
| 002109 | Hubert H. Fernandez [États-Unis] ; Edward M. Donnelly [États-Unis] ; Joseph H. Friedman [États-Unis] | Long-term outcome of clozapine use for psychosis in Parkinsonian patients |
| 002411 | Jan Herzog [Allemagne] ; Julia Reiff [Allemagne] ; Paul Krack [Allemagne] ; Karsten Witt [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Müller [Allemagne] ; Günther Deuschl [Allemagne] | Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease |
| 002789 | Drugs to treat dementia and psychosis | |
| 002825 | Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis] | Clozapine withdrawal symptoms in a Parkinson's disease patient |
| 002A33 | Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis] | Clozapine for the treatment of drug-induced psychosis in Parkinson's disease : Results of the 12 week open label extension in the PSYCLOPS trial |
| 002C32 | H. H. Fernandez [États-Unis] ; M. C. Lannon [États-Unis] ; J. H. Friedman [États-Unis] ; B. P. Abbott [États-Unis] | Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| 002C54 | J. H. Friedman [États-Unis] ; S. A. Factor | Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease |
| 002D45 | E. S. Molho [États-Unis] ; S. A. Factor [États-Unis] | Possible tardive dystonia resulting from clozapine therapy |
| 002D48 | G. Lera [Argentine] ; J. Zirulnik [Argentine] | Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced Parkinsonism |
| 002E71 | B. I. Karp [États-Unis, Canada] ; S. R. Goldstein [États-Unis, Canada] ; R. Chen [États-Unis, Canada] ; A. Samii [États-Unis] ; W. Bara-Jimenez [États-Unis, Canada] ; M. Hallett [États-Unis, Canada] | An open trial of clozapine for dystonia |
| 002E73 | R. Ceravolo [Italie] ; S. Salvetti [Italie] ; P. Piccini [Royaume-Uni] ; C. Lucetti [Italie] ; G. Gambaccini [Italie] ; U. Bonuccelli [Italie] | Acute and chronic effects of clozapine in essential tremor |
| 003057 | R. M. Trosch [États-Unis] ; J. H. Friedman [États-Unis] ; M. C. Lannon [États-Unis] ; R. Pahwa [États-Unis] ; D. Smith [États-Unis] ; L. C. Seeberger [États-Unis] ; C. F. O'Brien [États-Unis] ; P. A. Lewitt [États-Unis] ; W. C. Koller [États-Unis] | Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience |
| 003058 | I. Maurer [Allemagne] ; T. Grunwald [Allemagne] ; C. E. Elger [Allemagne] | Clozapine treatment of delayed-onset paroxysmal hemidystonia |
| 003059 | H. H. Fernandez [États-Unis] ; R. Durso [États-Unis] | Clozapine for dopaminergic-induced paraphilias in Parkinson's disease |
| 003099 | F. Delecluse [Belgique] ; J. A. Elosegi [Belgique] ; J.-M. Gerard [Belgique] | A case of tardive tremor successfully treated with clozapine |
| 003126 | S. A. Factor [États-Unis] ; J. H. Friedman [États-Unis] | The emerging role of clozapine in the treatment of movement disorders |
| 003198 | G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. T. Savino [Argentine] ; M. Mora [Argentine] ; F. J. E. Stefano [Argentine] ; O. Gershanik [Argentine] | Mechanism of action of clozapine-induced modification of motor behavior in an animal model of the "super-off" phenomenon |
| 003314 | M. Raja [Italie] ; G. Maisto [Italie] ; M. C. Altavista [Italie] ; A. Albanese [Italie] | Tardive lingual dystonia treated with clozapine |
| 003559 | J. M. Trugman [États-Unis] ; R. Leadbetter ; M. E. Zalis ; R. O. Burgdorf ; G. F. Wooten [États-Unis] | Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis |
| 003570 | J. P. Jr Bennett [États-Unis] ; E. R. Landow ; S. Dietrich ; L. A. Schuh | Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction |
| 003631 | J. H. Friedman [États-Unis] | Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases |
| 003706 | G. Linazasoro [Espagne] ; J. F. Marti Masso ; J. A. Suarez | Nocturnal akathisia in Parkinson's disease: treatment with clozapine |
| 003713 | G. J. Gomez Arevalo [Argentine] ; O. S. Gershanik | Modulator effect of clozapine on levodopa response in Parkinson's disease: a preliminary study |
| 003829 | S. A. Factor [États-Unis] ; D. Brown | Clozapine prevents recurrence of psychosis in Parkinson's disease |
| 003961 | J. H. Friedman ; M. C. Lannon | Clozapine-responsive tremor in Parkinson's disease |
| 003962 | R. F. Pfeiffer ; J. Kang ; B. Graber ; R. Hofman ; J. Wilson | Clozapine for psychosis in Parkinson's disease |
| This area was generated with Dilib version V0.6.23. |  |